These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16130462)

  • 1. Hypothalamo-pituitary-adrenocortical axis in stress-susceptible and stress-resistant pigs: endocrine responses to corticotrophin-releasing factor and vasopressin.
    Hari JJ; Pliska V
    J Anim Breed Genet; 2005 Apr; 122 Suppl 1():87-96. PubMed ID: 16130462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social setting, social rank and HPA axis response in cynomolgus monkeys.
    Jimenez VA; Allen DC; McClintick MN; Grant KA
    Psychopharmacology (Berl); 2017 Jun; 234(12):1881-1889. PubMed ID: 28332004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone inhibits ovine corticotrophin-releasing factor (oCRF), arginine vasopressin (AVP), and oCRF + AVP stimulated release of ACTH during the last third of pregnancy in the sheep fetus.
    Norman LJ; Challis JR
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1186-92. PubMed ID: 3040203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovine corticotrophin-releasing factor in dogs: dose-response relationships and effects of dexamethasone.
    Kemppainen RJ; Filer DV; Sartin JL; Reed RB
    Acta Endocrinol (Copenh); 1986 May; 112(1):12-9. PubMed ID: 3012925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stress and pituitary-adrenocortical responses to corticotropin-releasing hormone and vasopressin in female pigs.
    Janssens CJ; Helmond FA; Wiegant VM
    Eur J Endocrinol; 1995 Apr; 132(4):479-86. PubMed ID: 7711887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
    Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
    Clark DJ; Lipworth BJ
    Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy.
    Ford LR; Willi SM; Hollis BW; Wright NM
    J Pediatr; 1997 Nov; 131(5):722-6. PubMed ID: 9403653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
    Brooks AN; Challis JR; Norman LJ
    Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropin responses to endogenous and exogenous secretagogues in the sheep: specificity of glucocorticoid action.
    Canny BJ; Clarke IJ; Funder JW
    Neuroendocrinology; 1990 Feb; 51(2):181-9. PubMed ID: 2154716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adrenomedullin on adrenocorticotropic hormone (ACTH) release in pituitary cell cultures and on ACTH and oxytocin responses to shaker stress in conscious rat.
    Mimoto T; Nishioka T; Asaba K; Takao T; Hashimoto K
    Brain Res; 2001 Dec; 922(2):261-6. PubMed ID: 11743958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
    Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
    J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.